Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 8,252 shares at $114.15 ($959K) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($959k) by Chief Regulatory Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.15 | 865 | $99K | 10.3% |
| 2 | $114.15 | 865 | $99K | 10.3% |
| 3 | $116.74 | 1,490 | $174K | 18.1% |
| 4 | $116.74 | 1,490 | $174K | 18.1% |
| 5 | $116.87 | 1,015 | $119K | 12.4% |
| 6 | $116.87 | 1,015 |
| $119K |
| 12.4% |
| 7 | $116.89 | 756 | $88K | 9.2% |
| 8 | $116.89 | 756 | $88K | 9.2% |
| Total | $116.26 avg | 8,252 | $959K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |